EAHAD 2021 is underway and runs until February 5. Precision BioLogic and Affinity Biologicals are both presenting e-posters at the virtual event. Posters are also available for viewing and download from our websites:
Laboratory Validation of CRYOcheck™ Chromogenic Factor VIII Across Multiple Coagulation Analyzers, Precision BioLogic
Improved Recognition of B-Domain Deleted FVIII in Plasma with a New Commercially Available VisuLize™ F8Plus Antigen Kit, Affinity Biologicals
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the U.S. launch of its new CRYOcheck™ Hex LA™ kit. Expansion to the U.S. follows successful launches in Canada, the European Union, Australia, and New Zealand.
CRYOcheck Hex LA is intended for use in clinical labs to aid in the detection of lupus anticoagulant (LA) in human plasma. Hex LA is an integrated (screen and confirm) assay and, as its name suggests, applies hexagonal phase phospholipids. It is the first commercially available hexagonal phase LA test available in a frozen format, allowing for fast and easy preparation. Designed to work on many common automated coagulation analyzers, Hex LA offers valuable time savings to today’s busy labs.
Here’s a list of conferences we’ll be attending this year. If you’re planning on attending any of the same shows, be sure to swing by our booth for a chat because, after all, it’s you we want to see.